Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
04/11/2014 04/14/2014 04/15/2014 04/16/2014 04/17/2014 Date
48.83(c) 47.96(c) 48.17(c) 49.11(c) 49.46(c) Last
8 079 440 10 249 403 13 265 208 7 649 940 6 656 913 Volume
-0.93% -1.78% +0.44% +1.95% +0.71% Change
More quotes
Company
Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Its pharmaceutical products include chemically-synthesized drugs, or small molecules, and an increasing portion of products produced from... 
Surperformance© rating of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More about the company
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 15 587 M
EBIT 2014 3 333 M
Net income 2014 2 800 M
Debt 2014 2 048 M
Yield 2014 2,98%
Sales 2015 15 004 M
EBIT 2015 3 027 M
Net income 2015 2 373 M
Debt 2015 1 339 M
Yield 2015 3,05%
PER 2014 23,21
PER 2015 30,27
EV / Sales 2014 5,25x
EV / Sales 2015 5,41x
Capitalization 79 816 M
More Financials
Latest news on BRISTOL-MYERS SQUIBB CO
7h ago BRISTOL MYERS SQUIBB : Assigned Patent
1d ago BRISTOL MYERS SQUIBB : Reports Submission of New Drug Application to U.S. FDA fo..
2d ago BRISTOL MYERS SQUIBB : New Cholestasis Study Findings Have Been Reported by Inve..
2d ago BRISTOL MYERS SQUIBB : Study Results from Bristol-Myers Squibb Provide New Insig..
2d ago BRISTOL MYERS SQUIBB : Studies from Bristol-Myers Squibb Have Provided New Infor..
2d ago BRISTOL MYERS SQUIBB : Submits NDAs for Daclatasvir and Asunaprevir to US FDA fo..
2d ago BRISTOL MYERS SQUIBB : Presents Phase III Data Demonstrating that Investigationa..
2d ago BRISTOL MYERS SQUIBB : Findings on Hepatitis Reported by Investigators at Bristo..
2d ago BRISTOL MYERS SQUIBB : New Clinical Trials and Studies Study Findings Reported f..
2d ago Reckitt leans towards pharmaceuticals spin-off
4d ago BRISTOL MYERS SQUIBB : Submits New Drug Application to U.S. FDA for a Fixed-Dose..
4d ago BRISTOL MYERS SQUIBB : Highlights Phase III Data Demonstrates that Investigation..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Technical analysis
Income Statement Evolution
Bristol-Myers Squibb Co : Income Statement Evolution
More Financials
EPS Revisions
Bristol-Myers Squibb Co : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF